Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2.

Francini, Edoardo; Miano, Salvatora T; Fiaschi, Anna I; Francini, Guido

Francini, Edoardo; Miano, Salvatora T; Fiaschi, Anna I; Francini, Guido.

Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy. Electronic address: edoardo.francini@unifi.it.
Miano ST; Unit of Oncology, Santa Maria alle Scotte Hospital, Siena, Italy.
Fiaschi AI; Department of Pharmacology, Santa Maria alle Scotte Hospital, Siena, Italy.
Francini G; University of Siena, Siena, Italy.

Med Hypotheses ; 144: 110054, 2020 11.

Article in English | MEDLINE | ID: covidwho-624072

Subject(s)

COVID-19 Drug Treatment; Doxycycline/therapeutic use; Minocycline/therapeutic use; Anti-Bacterial Agents/therapeutic use; Humans; Inflammation; Models, Theoretical; RNA, Double-Stranded/metabolism; RNA, Ribosomal, 16S/metabolism; RNA, Viral/metabolism; Signal Transduction

Keywords

COVID-19; Doxycycline; Minocycline; SARS-CoV-2; Tetracyclines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Doxycycline / COVID-19 Drug Treatment / Minocycline Limits: Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google